CTLA4 and melanoma: Another analysis of 77 patients with advanced melanoma revealed a positive correlation between the toxicity of anti-PD-1 and anti-CTLA-4 antibodies and the presence of Bacteroides intestinalis in the feces of the patients, suggesting that the bacteria could be used as a target for reducing the side effects of ICB treatment [96].